BetterScholar BetterScholar
9
Role
Title
Level Year L/R
🐜 Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
15 auth. S. Appel-Cresswell, C. Vilariño-Gúell, M. Encarnacion, Holly E. Sherman, Irene Yu, Brinda Shah, David Weir, Christina Thompson, C. Szu‐Tu, J. Trinh, ... J. Aasly, A. Rajput, A. Rajput, A. Stoessl, M. Farrer
9 2013
9
🐜
🐜 DNAJC13 mutations in Parkinson disease.
40 auth. C. Vilariño-Güell, A. Rajput, A. Milnerwood, Brinda Shah, C. Szu‐Tu, J. Trinh, Irene Yu, M. Encarnacion, Lise N. Munsie, L. Tapia, E. Gustavsson, Patrick Chou, Igor Tatarnikov, Daniel M. Evans, F. Pishotta, ... Mattia Volta, Dayne A Beccano-Kelly, Christina Thompson, Michelle K. Lin, Holly E. Sherman, Heather Han, Bruce L. Guenther, W. Wasserman, V. Bernard, C. Ross, S. Appel-Cresswell, A. Stoessl, C. Robinson, D. Dickson, O. Ross, Z. Wszolek, J. Aasly, R. Wu, F. Hentati, R. Gibson, P. McPherson, M. Girard, M. Rajput, A. Rajput, M. Farrer
8 2014
8
🐜
🐬 Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension
Jennifer D. Reid, Daniel T. Holmes, D. Randal Mason, Brinda Shah, Christoph H. Borchers
6 2010
6
🐬
🐜 STX6 rs1411478 is not associated with increased risk of Parkinson's disease.
12 auth. J. Trinh, C. Vilariño-Güell, Alan Donald, Brinda Shah, Irene Yu, C. Szu‐Tu, ... J. Aasly, R. Wu, F. Hentati, A. Rajput, A. Rajput, M. Farrer
4 2013
4
🐜
🦁 Developing an iMALDI method.
Brinda Shah, Jennifer D. Reid, M. Kuzyk, C. Parker, C. Borchers
3 2013
3
🦁
🦁 Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
Brinda Shah, Rachel L. Kozlowski, Jun Han, C. Borchers
2 2011
2
🦁
🦁 Toll-like receptor 4 activity promotes immunosuppression in the cutaneous T-cell lymphoma microenvironment
Brinda Shah, E. Correia, P. Porcu, N. Nikbakht
0 2021
0
🦁
🦁 The development of an antibody affinity enrichment and mass spectrometry-based assay (iMALDI) for the characterization of EGFR and EGFR isoforms from human brain cancer tissue
Brinda Shah
0 2011
0
🦁
🐜 Abstract 4053: A mesothelin targeting chimeric antigen receptor macrophage (CAR-M) for solid tumor immunotherapy: pre-clinical development of CT-1119
12 auth. N. Anderson, Brinda Shah, Alison Worth, R. Gabbasov, Brett Menchel, Kerri Ciccaglione, ... D. Blumenthal, S. Pierini, S. DeLong, S. Abramson, T. Condamine, M. Klichinsky
0 2023
0
🐜